浜у搧涓績
鑱旂郴鎴戜滑
閿€鍞笓鐢細
鍦板潃锛氬寳浜競娴锋穩鍖鸿タ灏忓彛璺?6鍙蜂腑鍏虫潙涓滃崌绉戞妧鍥瑿-1妤间笁灞侟/p>

- 浜у搧鎻忚堪
- 鍙傝€冩枃鐚
-
銆€銆€Y鍨嬭仛涔欎簩閱囬┈鏉ラ叞浜氳兒鏄兘鍦≒H=5-6鐨勬潯浠朵笅涓庡矾鍩鸿繘琛屽弽搴旂殑鍏锋湁Y鍒嗘敮鐨勮仛涔欎簩閱囪鐢熺墿銆傞敭鍑骇鍝乊鍒嗘敮琛嶇敓鐗╂槸鑷富鐮斿彂鐨刌鍨嬬粨鏋勶紝鐢变簬鍏锋湁鐙壒鐨勭┖闂寸粨鏋勪娇浠栦滑姣旂嚎鎬ц仛涔欎簩閱囪鐢熺墿鏇村叿鏈夐€夋嫨鎬с€侟/p>
銆€銆€閿嚡绉戞妧鎻愪緵鍒嗚鏈嶅姟锛岄渶瑕佹敹鍙栧垎瑁呰垂鐢紝濡傛灉鎮ㄩ渶瑕佸垎瑁呬负鍏朵粬瑙勬牸璇蜂笌鎴戜滑鑱旂郴銆侟/p>
銆€銆€閿嚡绉戞妧鍚屾椂鎻愪緵鍏朵粬鍒嗗瓙閲忕殑Y鍨嬭鐢熺墿浜у搧锛屽浣犻渶瑕佽涓庢垜鍙竤ales@jenkem.com鑱旂郴銆侟/p>
銆€銆€閿嚡绉戞妧鎻愪緵澶ф壒閲忕敓浜т骇鍝佸強GMP绾у埆浜у搧锛屽闇€鎶ヤ环璇蜂笌鎴戜滑鑱旂郴銆侟/p>
-
銆€銆€References:
銆€銆€1. Li, H., et al., Dual MMP7-Proximity-Activated and Folate Receptor-Targeted Nanoparticles for siRNA Delivery, Biomacromolecules, 2015, 16 (1), p. 192–201.
銆€銆€2. Yu, W., et al., PEGylated recombinant human interferon-ω as a long-acting antiviral agent: Structure, antiviral activity and pharmacokinetics. Antiviral Research, 2014, 108, p. 142-147.
銆€銆€3. Fang, L., et al., Rational design, preparation, and characterization of a therapeutic enzyme mutant with improved stability and function for cocaine detoxification. ACS chemical biology, 2014, 9(8), 1764-72.
銆€銆€4. Fang, L., Computational Modeling, Design, And Characterization Of Cocainemetabolizing Enzymes For Anticocaine Medication, UKY, 2013, 39.
銆€銆€5. Resch, G., P. Moreillon, and V.A. Fischetti, PEGylating a bacteriophage endolysin inhibits its bactericidal activity. AMB Express, 2011, 1(29), p. 1-5.
銆€銆€6. Narasimhan, D., et al., Subunit Stabilization and Polyethylene Glycolation of Cocaine Esterase Improves In Vivo Residence Time, Mol Pharmacol, 2011, 80:1056–1065.
銆€銆€7. Park, J.-B., et al., PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity, Journal of Controlled Release, 2010, 142(2), p. 174-179.
浜у搧璇环